Key terms
About STAA
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest STAA news
Apr 11
7:04am ET
Staar Surgical price target raised to $53 from $45 at Mizuho
Apr 09
8:10am ET
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
Apr 08
7:35am ET
Staar Surgical price target raised to $46 from $32 at Canaccord
Apr 05
6:55am ET
Staar Surgical Holds Promise Amid Strong Q1 Performance, Yet Cautious Outlook Justifies Hold Rating
Apr 04
3:25pm ET
Staar Surgical upgraded to Outperform after Q1 beat at William Blair
Apr 04
2:53pm ET
Staar Surgical upgraded to Outperform from Market Perform at William Blair
Apr 04
9:10am ET
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Schrodinger (SDGR)
Apr 04
7:09am ET
Staar Surgical reports preliminary Q1 revenue in excess of $77M, consensus $72M
Apr 01
8:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Mar 18
7:22am ET
Staar Surgical Highlights Milestone and Investor Engagement
Mar 12
8:36pm ET
Staar Surgical initiated with an Outperform at CICC
Mar 12
7:22am ET
STAAR Surgical Enhances Board with Strategic Appointments
Mar 11
4:45am ET
Staar Surgical upgraded to Buy from Hold at Stifel
Mar 11
4:36am ET
Buy Rating Affirmed for Staar Surgical Amidst Growth Potential and Market Headwinds
Feb 28
5:44pm ET
Staar Surgical’s Financial Performance Conference Overview
Feb 28
7:27am ET
Staar Surgical price target lowered to $45 from $50 at Mizuho
Feb 27
8:28am ET
Staar Surgical price target raised to $32 from $31 at Canaccord
Feb 27
7:43am ET
Piper Sandler Remains a Hold on Staar Surgical (STAA)
Feb 27
7:41am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), IQVIA Holdings (IQV) and Bausch Health Companies (BHC)
Feb 27
7:27am ET
Staar Surgical price target lowered to $33 from $40 at Piper Sandler
Feb 27
6:02am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)
Feb 26
4:02pm ET
Staar Surgical sees FY24 revenue $335M-$340M, consensus $348.96M
Feb 26
4:02pm ET
Staar Surgical reports Q4 EPS 16c, consensus 17c
Feb 13
8:27am ET
Buy Rating Justified for Staar Surgical Amidst Chinese Market Dominance and US Strategic Enhancements
Jan 23
7:05am ET
Staar Surgical announces strategic pact in U.S. with SharpeVision, no terms
Jan 22
7:05am ET
Staar Surgical price target lowered to $31 from $33 at Canaccord
No recent press releases are available for STAA
STAA Financials
Key terms
Ad Feedback
STAA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
STAA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
